Tests on peripheral blood cells in multiple sclerosis. by McCrea, S. et al.
TESTS ON PERIPHERAL BLOOD CELLS IN
MULTIPLE SCLEROSIS
by
Susan McCrea, M. Killen, J. Thompson, W. A. Fleming,
T. A. McNeill and J. H. D. Millar
Department of Microbiology and Immunobiology
The Queen's University of Belfast and Department of Neurology,
Royal Victoria Hospital, Belfast.
IMMUNOLOGICAL and epidemiological investigations have suggested that
the multiple sclerosis (MS) reaction results from an abnormal response to a
common childhood infection in individuals with a predisposing genetic con-
stiution governed by the major histocompatibilitiy complex. Much effort has
gone into the quest for specific infectious agents. Serological studies have pointed
towards several 'membrane-associated' viruses as the most likely candidates,
with measles being dominant amongst these (Fraser 1977).
The basic defect in MS could be an abnormality of cell membrane function
which may not necessarily become manifest as a specific immunological defect
or abnormal reactivity to specific microbial antigens. Looked at from this point
of view abnormal responses to certain membrane viruses may indicate a non-
specific abnormality rather than involvement of the particular virus in the disease
process. Accordingly, in a study of peripheral blood cell activity in MS we have
chosen to emphasize non-specific rather than antigen-specific aspects of cellular
function such as blastogenic response to phytohaemagglutinin (PHA), interferon
response to a virus inducer, leukocyte bactericidal and chemotactic responses
and erythrocyte fragility. Because of the relatively large number of patients
available for study and in view of some discordance in the literature regarding
abnormality in numbers of peripheral blood cells showing markers associated
with B and T lymphocytes (Sekizawa et al, 1974; Nowak and Wajgt, 1975; Oger
et al, 1975; Lisak et al, 1975; Reddy and Goh, 1976; Lamoureux et al, 1976;
Platz et al, 1976; Schauf et al, 1977; Nordal and Froland, 1978; Symington et al,
1978), we also investigated these parameters.
These studies have been carried out in a group of patients of similar racial
origin living in an area where there is a high incidence of the disease (Allison
& Millar, 1954).
MATERIALS AND METHODS
Patients
The 76 patients who provided specimens were aged between 17 and 68 years
(mean 45 ± 11), 46 were female and 30 male. All were clinically 'probable'
cases of MS as defined by Allison and Millar (1954). Most blood samples were
obtained when the patients were attending out-patient clinics for routine review.
Patients with severe debilitating illness were not included.
83Controls
Blood specimens were obtained from normal healthy blood donors by courtesy
of the Northern Ireland Blood Transfusion Service. For comparison with patient
groups results from controls were selected to give an age and sex match for
each patient.
Blood was collected in non-siliconized glass bottles with preservative-free
heparin as anticoagulant (10 u/ml). Separation of cells from both patient and con-
trol specimens was always started within one hour of venepuncture Leucocyte
preparations were obtained by layering blood on Ficoll-Triosil (Boyum, 1968)
and allowing erythrocytes to sediment out at Ixg for 30-40 minutes. Mononuclear
cell preparations were obtained by centrifugation of blood on Ficoll-Triosil
(400xg, 20 min.). Cell suspensions were washed twice with serum-free Eagle's
medium (BHK Eagle's Wellcome Reagents Ltd., Beckenham).
Cell Surface Markers
E-rosette-forming cells were detected according to the method of Pang,
Baguley and Wilson (1974). An E-rosette-forming cell was defined as a lympho-
cyte with three or more adherent erythrocytes. EAC-rosette-forming cells were
detected according to the method of Luckasen et al (1974) using sheep erythro-
cytes sensitized with Wellcome rabbit anti-serum and normal mouse serum as
the source of complement. Cells bearing surface membrane immunoglobulin
(SmIg) were detected by direct immunofluorescence using either a polyvalent
sheep anti-globulin (Wellcome), or immunoglobulin class-specific antisera obtained
from Wellcome (anti-IgG, anti-IgM), Meloy (anti-IgA) or Department of
Immunology, Birmingham University (anti-IgD, anti-IgE). The anti-IgA was
of goat origin, the others were produced in sheep. Staining of mononuclear cells
was performed at 00 for two hours followed by washing with phosphate-buffered
saline (PBS) at 40.
Serum IgA
The level of Iga in serum was determined by immunodiffusion using the
'precision' method with Hyland Immunoplates.
Lymphocyte responses to PHA
The method was based on that described by Penhale et al (1974) using 5 x 105
mononuclear cells in Eagle's medium containing 10 per cent foetal calf serum
per Microtiter well. The duration of culture was 72 hours and 1 ,u Ci. tritriated
thymidine (5 ci. per m. mol, Amersham) was added to each well for the last
six hours of culture. The same batch of PHA (PHA-P, Difco) was used for all
tests and five concentrations used to give final dilutions in culture from 1/500-
1/8000, three cultures being used for each dilution. Results were expressed as
the mean c.p.m. in stimulated cultures minus the mean c.p.m. in unstimulated
cultures.
84interferon response to Newcastle Disease Virus (NDV)
In this test 3 x 105 mononuclear cells were mixed with 256 haemagglutinating
units of NDV (avirulent Ulster strain) in 1.5 ml balanced salt solution containing
6 per cent heat-activated human AB serum. After two hourse incubation at
370 excess virus was removed by washing the cells which were suspended in
fresh medium and cultured for 22 hours at 370 in an atmosphere of 5 per cent
CO2 in air. The culture medium was then harvested, dialysed against glycine
buffer (pH 3) for three days and stored at -70°. Interferon was assayed on
secondary bovine kidney cells (Gresser et al (1974) by inhibition of encephalo-
myocarditis virus plaques. Titres were calculated as the dilution which inhibited
50 per cent of plaques. Equal numbers of media from control and MS cell
cultures were tested in each set of interferon assays.
Leucocyte bactericidal activity
Intracellular killing of Staphylococcus aureus (Oxford strain) was measured
by the method of van Furth and van Zwet (1973). The killing index (K60) was
calculated as log N. - log N6o where No was the number of viable intracellular
bacteria at the end of the initial fifteen minute phagocytosis phase and N60 the
number of viable intracellular bacteria sixty minutes later.
Chemotaxis assay
Leucocyte chemotaxis was measured in stainless steel chambers obtained
from Schleicher and Schull Inc., New Hampshire. Chambers were divided into
upper and lower compartments by a Selectron filter (25 mm diameter, pore size
3 Mtm, type AE97). A solution of casein (5 mg/ml) in Gey's solution was injected
into the lower compartment to provide a chemotactic stimulus and 1 ml of
leucocyte suspension (2.5 x 106 cells) placed in the upper compartment. Control
chambers contained Gey's solution in the lower compartment. After incubation
at 370 for 30 minutes filters were removed, fixed in absolute alcohol and stained
with haematoxylin (Wilkinson 1974). The chemotactic response was assessed by
the leading front method (Zigmond and Hirsch 1973) and the results expressed
as net migration (um) towards the casein attractant.
Erythrocyte fragility
Thirty ,u whole blood was added to 3 ml of various reagents and held at
room temperature for 45 minutes. Lysis was measured by spectrophotometry of
supernatants for ha-emoglobin. The reagents used were (a) dimethyl sulphoxide
(Hopkin and Williams) 42 per cent v/v in PBS, (b) lysolecithin (Sigma) diluted
in PBS (c) Phospholipase C (Lecithinase C-CL. welchii. Sigma) diluted in PBS
and (d) hypotonic saline - various concentrations of NaCl in Sorensen's phos-
phate buffer.
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Results for all patient and control groups were compared on the basis of
mean + one standard deviation (S.D.). Student's t-test was applied to difference
between the mean values of PHA responses, bactericidal activity and erythrocyte
fragility to phospholipase C.
RESULTS AND DISCUSSION
Leucocyte bactericidal activity
Cells from groups of sixteen patients and controls gave mean K60 values of
0.6110 ± 0.2870 for the MS group and 0.9547 ± 0.3635 for the control group.
This difference was not significant.
Leucocyte chemotaxis
Groups of twelve patients and controls were compared. Mean net migration
towards casein was 122 ± 39 ,um for the MS and 143 ± 48 ,fm for the control
group.
Monocyte responses to PHA
The increment of 3H thymidine incorporated in response to five concentrations
of PHA shows that compared with controls MS cells were marginally less
responsive to stimulation by the three lower concentrations (Table 1). Other
TABLE 1
increase in tritiated thymidine uptake in response to different PHA
concentrations. Values given as mean c.p.m. increment + one standard
deviation
Phytohaemagglutinin Concentration
1/500 1/1000 1/2000 1/4000 1/8000
Controls (14) 10056 11612 11821 10118 7048
+ 7500 ± 11680 ± 14278 ± 15458 ± 13130
MS (14) 6204 5144 2716 1770 790
± 13147 + 10009 ± 2841 ± 2268 ± 818
Significance
of difference N.S. N.S. 0.05>p>0.025 p>0.05 0.1>p>0.05
reports on blastogenic lymphocyte responses to PHA in MS have been con-
flicting (Jensen, 1968; Dau and Peterson, 1970; Davis et al, 1972; Offner et al,
1974; Knight et al, 1975; Lamoureux et al, 1976; Platz et al, 1976; Symington
86et al, 1978). If the diminished response of MS cells to PHA is manifest only
with sub-optimal concentrations of the mitogen as the present results suggest,
then, since most other studies have used a single concentration, the level at
which this was chosen would obviously affect the result obtained.
Monocyte interferon response to NDV
Cells from groups of twelve patients and controls were tested. There was no
difference between the two groups -mean interferon titres were 1/5000 in the
control group and 1/4000 in the MS group.
Monocyte membrane markers
The absolute numbers and percentages of cells demonstrating E-rosette,
EAC-rosette and SmIg markers are shown in Table 2 for MS and normal groups.
These tests were performed on sufficient numbers of patients to allow division
TABLE 2
Monocyte surface markers. Values given are the mean numbers of cells x 10-3
per ml blood + one standard deviation with the percentage of cells positive for
each marker given in parenthesis
All Control All MS 'Steriod' MS 'Non-Steroid'
MS
(59) (59) (16) (43)
E-Rosette 119 ± 47 141 ± 74 165 ± 98 138 ± 66
(68 + 9) (65 ± 11) (62 ± 11) (66 ± 11)
EAC-Rosette 53 ± 20 83 ± 47 106 ± 67 74 3 33
(31 ± 6) (37± 8) (38± 9) (37± 2)
SmIg 53 ±59 79 47 98 ±66 74 ±39
(30 ± 7) (37 ± 13) (38 ± 14) (36 ± 13)
into a 'steroid' group (those receiving corticosteroids or corticotrophin) and a
'non-steroid' group. Although none of the differences between groups was
significant it can be noted that the mean values for the 'steroid' group for all
three markers showed a greater difference compared with control than those
for the 'non-steroid' group. No results from patients receiving steroid therapy
have been included in any other patient groups reported in this paper.
Numbers and percentages of cells showing SmIg for each immunoglobulin
class are shown in Tabe 3. The only hint of difference was the slightly larger
number and percentage of MS cells which reacted with the anti-IgA reagent.
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Number and percentages of monocytes expressing Ig class-specific markers
Values given as in Table 2
SmIgG SmIgM SmIgA SmIgD SmIgE
(31) (31) (16) (14) (14)
Controls 27 15 30 21 17 9 41 28 22 17
(15± 7) (15 7) (9 4) (22 7) (11± 5)
'Non-Steroid' 37 ± 33 39 ± 30 35 ± 25 56 ± 30 22 ± 16
MS (15 10) (17 8) (16 11) (27± 7) (11 ± 7)
Investigations of serum IgA in MS patients gave higher mean values than
controls (4.36 ± 1.88 g per 1 compared with 2.90 + 1.71 and measurement of
serum IgA in 18 specimens from each of four patients over an 18 month period
showed that two out of four had levels consistently in excess of the normal
mean value (i) mean 4.43 g per 1, range 3.24 - 5.75: (ii) mean 4.69, range 3.75 -
6.25) whereas the other two did not. There is therefore no consist-ent association
of elevated serum IgA with MS.
Erythrocyte fragility
No significant differences were found between groups of 12 MS and control
individuals with respect to fragility of erythrocytes in hypotonic saline, dimethyl
sulphoxide, lysolecithin or phospholipase C. Caspary et al (1967) reported
increased osmotic fragility of erythrocytes from patients with active but not with
quiescent MS. Our results are in agreement with this insofar as our patients
were not acutely ill with the disease.
The present observations have extended previously reported attempts to
define an immunological 'profile' in MS (Lamoureux et al, 1976; Symington et al,
1978) by applying a number of non-specific tests to peripheral blood cells. A
tendency to diminished function in the MS patients was suggested but no
significant and characteristic abnormality was defined. We therefore conclude
that either (i) there is no systemic immunological or cellular 'fault' in MS as
concluded by Symington et al (1978), or (ii) the nature of the fault is such that
presently available techniques are unable to define it, or (iii) the 'fault' may
manifest itself in different ways in different patients. Although we do not have
comparative data from normal individuals the observation of persistent elevation
of serum IgA in some MS patients is of interest in this context.
SUMMARY
Four tests of cellular function - PHA response, interferon release, bacteri-
cidal activity and chemotactic response - all gave lower mean values for multiple
sclerosis (MS) groups than for age-and-sex-matched control groups. In only one
of the tests (PHA response) did the differences approach statistical significance
88and then only when the lower range of PHA concentrations are used. No
differences were found between MS and control groups when erythrocyte
fragility was tested with hypotonic saline, dimethyl sulphoxide, lysolecithin or
phospholipase C. Investigation of lymphocyte surface markers - E-rosettes,
EAC-rosettes, and surface immunoglobulin (including class-specific tests) did not
show any significant differences between patients and controls.
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